Two-dimensional structure of β-amyloid(10-35) fibrils

被引:186
作者
Benzinger, TLS
Gregory, DM
Burkoth, TS
Miller-Auer, H
Lynn, DG
Botto, RE
Meredith, SC
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
[3] Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA
关键词
D O I
10.1021/bi991527v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Amyloid (A beta) peptides are the main protein component of the pathognomonic plaques found in the brains of patients with Alzheimer's disease. These heterogeneous peptides adopt a highly organized fibril structure both in vivo and in vitro. Here we use solid-state NMR on stable, homogeneous fibrils of A beta((10-35)) Specific interpeptide distance constraints are determined with dipolar recoupling NMR on Fibrils prepared from a series of singly labeled peptides containing C-13-carbonyl-enriched amino acids, and skipping no more that three residues in the sequence. From these studies, we demonstrate that the peptide adopts the structure of an extended parallel beta-sheet in-register at pH 7.4. Analysis of DRAWS data indicates interstrand distances of 5.3 +/- 0.3 Angstrom (mean +/- standard deviation) throughout the entire length of the peptide, which is compatible only with a parallel beta-strand in-register. Intrastrand NMR constraints, obtained from peptides containing labels at two adjacent amino acids, confirm the secondary structural findings obtained using DRAWS. Using peptides with C-13 incorporated at the carbonyl position of adjacent amino acids, structural transitions from alpha-helix to beta-sheet were observed at residues 19 and 20, but using similar techniques, no evidence for a turn could be found in the putative turn region comprising residues 25-29, Implications of this extended parallel organization for A beta((10-35)) for overall fibril formation, stability, and morphology based upon specific amino acid contacts are discussed.
引用
收藏
页码:3491 / 3499
页数:9
相关论文
共 78 条
  • [21] Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence
    Esler, WP
    Stimson, ER
    Ghilardi, JR
    Lu, YA
    Felix, AM
    Vinters, HV
    Mantyh, PW
    Lee, JP
    Maggio, JE
    [J]. BIOCHEMISTRY, 1996, 35 (44) : 13914 - 13921
  • [22] A beta deposition inhibitor screen using synthetic amyloid
    Esler, WP
    Stimson, ER
    Ghilardi, JR
    Felix, AM
    Lu, YA
    Vinters, HV
    Mantyh, PW
    Maggio, JE
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (03) : 258 - 263
  • [23] CONFORMATION AND FIBRILLOGENESIS OF ALZHEIMER A-BETA PEPTIDES WITH SELECTED SUBSTITUTION OF CHARGED RESIDUES
    FRASER, PE
    MCLACHLAN, DR
    SUREWICZ, WK
    MIZZEN, CA
    SNOW, AD
    NGUYEN, JT
    KIRSCHNER, DA
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 244 (01) : 64 - 73
  • [24] MORPHOLOGY AND ANTIBODY RECOGNITION OF SYNTHETIC BETA-AMYLOID PEPTIDES
    FRASER, PE
    DUFFY, LK
    OMALLEY, MB
    NGUYEN, J
    INOUYE, H
    KIRSCHNER, DA
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 28 (04) : 474 - 485
  • [25] FIBRIL FORMATION BY PRIMATE, RODENT, AND DUTCH-HEMORRHAGIC ANALOGS OF ALZHEIMER AMYLOID BETA-PROTEIN
    FRASER, PE
    NGUYEN, JT
    INOUYE, H
    SUREWICZ, WK
    SELKOE, DJ
    PODLISNY, MB
    KIRSCHNER, DA
    [J]. BIOCHEMISTRY, 1992, 31 (44) : 10716 - 10723
  • [26] PH-DEPENDENT STRUCTURAL TRANSITIONS OF ALZHEIMER AMYLOID PEPTIDES
    FRASER, PE
    NGUYEN, JT
    SUREWICZ, WK
    KIRSCHNER, DA
    [J]. BIOPHYSICAL JOURNAL, 1991, 60 (05) : 1190 - 1201
  • [27] Soluble amyloid A beta-(1-40) exists as a stable dimer at low concentrations
    GarzonRodriguez, W
    SepulvedaBecerra, M
    Milton, S
    Glabe, CG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) : 21037 - 21044
  • [28] Assembly and architecture of invertebrate cytoplasmic intermediate filaments reconcile features of vertebrate cytoplasmic and nuclear lamin-type intermediate filaments
    Geisler, N
    Schünemann, J
    Weber, K
    Häner, M
    Aebi, U
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 282 (03) : 601 - 617
  • [29] ALZHEIMERS-DISEASE AND DOWNS-SYNDROME - SHARING OF A UNIQUE CEREBROVASCULAR AMYLOID FIBRIL PROTEIN
    GLENNER, GG
    WONG, CW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (03) : 1131 - 1135
  • [30] 10 TO 14 RESIDUE PEPTIDES OF ALZHEIMERS-DISEASE PROTEIN ARE SUFFICIENT FOR AMYLOID FIBRIL FORMATION AND ITS CHARACTERISTIC X-RAY-DIFFRACTION PATTERN
    GOREVIC, PD
    CASTANO, EM
    SARMA, R
    FRANGIONE, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (02) : 854 - 862